ovarian cancer: what is the role of hrd testing?
Published 3 years ago • 1.8K plays • Length 6:28Download video MP4
Download video MP3
Similar videos
-
0:52
the importance of hrd testing in ovarian cancer
-
4:42
treatment of hrd-negative ovarian cancer
-
8:41
impact of hrd status on frontline treatment of ovarian cancer
-
1:17
dr. brown on the importance of genetic testing in ovarian cancer
-
45:27
what is hrd (homologous recombination deficiency) and how does it impact ovarian cancer?
-
59:08
hrd testing in ovarian cancer - what do you need to consider?
-
2:39
testing for brca and hrd in ovarian cancer
-
3:46
illumina oncology - homologous recombination deficiency (hrd) testing in ovarian cancer
-
6:08
treating ovarian cancer based on hrd status
-
3:46
introduction to homologous recombination deficiency (hrd) assessment
-
1:36
jerry lanchbury, phd, describes myriad's hrd test
-
1:21
evaluating the interchangeability of hrd testing in ovarian cancer
-
1:13:10
the state of ovarian cancer: exploring the landscape of systemic therapy
-
12:05
the rationale for hrd genomic instability testing in patients with advanced ovarian cancer
-
7:30
somatic mutation testing for ovarian cancer
-
6:01
classification of ovarian cancers
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
6:21
parp inhibition in brca1/2 or hrd- ovarian cancer
-
29:07
actg dinner symposium highlights | beyond brca testing – does hrd matter? | prof michael friedlander